PHARVARIS NV (PHVS:NASDAQ)
$34.94 1.28 (3.8027%)
Analysed PHARVARIS NV (PHVS:NASDAQ) News Sources
Pharvaris Equity Raise Supports Late Stage HAE Push And Valuation Case
14-05-2026
yahoo.com
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
19-05-2026
fool.com
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026
29-05-2026
yahoo.com
Pharvaris Announces Annual General Meeting of Shareholders
11-06-2026
yahoo.com
Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026
15-06-2026
yahoo.com
Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks
06-07-2026
yahoo.com
Why This Biotech, Up 12% Since Its Breakout, Yo-Yoed On A Key FDA Development
06-07-2026
yahoo.com
Wall Street Analysts Believe Pharvaris (PHVS) Could Rally 36.16%: Here's is How to Trade
14-07-2026
yahoo.com
IBM downgraded, Cava upgraded: Wall Street's top analyst calls
15-07-2026
yahoo.com
Here's Why Pharvaris N.V. (PHVS) is a Great Momentum Stock to Buy
15-07-2026
yahoo.com
What is the current price of PHARVARIS NV (PHVS:NASDAQ)?
The current price of PHARVARIS NV (PHVS:NASDAQ) is $34.94.
PHARVARIS NV (PHVS:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHARVARIS NV (PHVS:NASDAQ) since the previous trading day is $1.28.
PHARVARIS NV (PHVS:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHARVARIS NV (PHVS:NASDAQ) since the previous trading day is 3.8027%.
What is the most recent average sentiment score for PHARVARIS NV (PHVS:NASDAQ)?
The most recent average sentiment score for PHARVARIS NV (PHVS:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for PHARVARIS NV (PHVS:NASDAQ)?
The most recent sentiment for PHARVARIS NV (PHVS:NASDAQ) is .
SEC-8K** Filing Available For PHARVARIS NV (PHVS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.